| Literature DB >> 31690021 |
Yaohao Tang1,2, Xiaoyan Li3,4, Hesheng Xiao5,6, Minghui Li7,8, Yueqin Li9,10, Deshou Wang11,12, Ling Wei13,14.
Abstract
The Sox family member Sox30 is highly expressed in the testis of several vertebrate species and has been shown to play key roles in spermiogenesis. However, its transcription regulation remains unclear. Here, we analyzed the Sox30 promoter from the teleost fish Nile tilapia (Oreochromis niloticus) and predicted a putative cis-regulatory element (CRE) for doublesex and mab-3 related transcription factor 1 (Dmrt1), a male-specific transcription factor involved in male sex differentiation. Transcriptional profiling revealed that Sox30 and Dmrt1 similarly exhibited a high expression in tilapia testes from 90 days after hatching (dah) to 300 dah, and the transcription of the Sox30 gene was reduced about one-fold in the testes of male tilapia with Dmrt1 knockdown. Further dual-luciferase reporter assay confirmed that Dmrt1 overexpression significantly promoted transcriptional activity of the Sox30 promoter and this promotion was decreased following the mutation of putative CRE for Dmrt1 within the Sox30 promoter. Chromatin immunoprecipitation-based PCR (ChIP-PCR) and electrophoretic mobility shift assay (EMSA) demonstrated that Dmrt1 directly binds to putative CRE within the Sox30 promoter. These results together indicate that Dmrt1 positively regulates the transcription of the tilapia Sox30 gene by directly binding to specific CRE within the Sox30 promoter.Entities:
Keywords: Dmrt1; Nile tilapia; Sox30; transcriptional regulation
Mesh:
Substances:
Year: 2019 PMID: 31690021 PMCID: PMC6862701 DOI: 10.3390/ijms20215487
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Cloning and sequencing of the Nile tilapia Sox30 promoter. (A) Cloning of the proximal promoter region containing a 1982 bp sequence upstream of the translational initiation site (ATG) of the Nile tilapia Sox30 gene. The first nucleotide of the transcription initiation site (ATG) is defined as +1 and its upstream region is indicated as minus number. (B) Bioinformatics prediction of potential cis-regulatory elements (CREs) for transcription factors within proximal promoter of the Nile tilapia Sox30 gene. The predicted TATA box and CREs for the binding of various transcription factors are underlined. The putative translation start site is indicated by the solid triangle. The potential core binding site for doublesex and mab-3 related transcription factor 1 (Dmrt1) located in the region from −274 to −254 within the Nile tilapia Sox30 promoter.
Figure 2Expression patterns of Sox30 and Dmrt1 in the Nile tilapia testis. (A) Transcriptome-based analysis of expression patterns of Sox30 and Dmrt1 in the gonads of the Nile tilapia during different developmental stages. The Reads Per Kilobase per Million mapped reads (RPKM) value was used to evaluate the expression level. dah, days after hatching; XX, female gonad; XY, male gonad. (B) Fluorescent in situ hybridization analysis of expression patterns of Sox30 and Dmrt1 in the gonads of male Nile tilapia at 90 dah. Double-colored fluorescent in situ hybridization was carried out on cross sections of male gonads at 90 dah. The below images were separately enlarged according to the regions indicated above images. The result shows that Sox30 and Dmrt1 are co-expressed in the epithelial cells comprising the efferent duct. White arrowheads indicate epithelial cells. scale bars =20 μm. ED, efferent duct.
Figure 3Change of Sox30 expression in the testes of Dmrt1-deficient Nile tilapia. Sox30 expression was detected by quantitative RT-PCR in the testes of male Nile tilapia with Dmrt1 knockdown at 90 dah. KD, knockdown. The experiments were independently repeated three times. The data are presented as the means ± SE of the triplicates. **, p < 0.01, compared with the control.
Figure 4Effects of Dmrt1 overexpression on the activity of the Nile tilapia Sox30 promoter. (A) Western blotting validation of the overexpression of the Nile tilapia Dmrt1 gene in human HEK293 cells. Cell lysates and total proteins were prepared separately from the cells with and without Dmrt1 overexpression. Anti-Dmrt1 antibody and anti-Tubulin antibody were used. (B) Dosage-dependent effects of Dmrt1 overexpression on the luciferase expression driven by the Sox30 promoter in human HEK293 cells. Different dosage of pcDNA3.1-Dmrt1 overexpressing vectors were separately co-transfected into HEK293 cells with a construct containing a luciferase reporter driven by the Nile tilapia Sox30 promoter. An empty construct without Dmrt1 was used as the control. Luciferase reporter analysis indicates that Dmrt1 overexpression promoted the activities of the Nile tilapia Sox30 promoter in a dosage-dependent manner. (C) Effects of Dmrt1 overexpression on the luciferase expression driven by several 5′-truncated regions of the Sox30 promoter in HEK293 cells. (D) Effects of Dmrt1 overexpression on the activity of the Nile tilapia Sox30 promoter with a mutation of putative CRE for Dmrt1. The data represent the means + SE (n = 3). Different letters above the error bars in (B) and (C) indicate statistical differences at p < 0.05, as determined by one-way ANOVA followed by the post hoc test in (B). *, p < 0.05; and **, p < 0.01 compared with the control in (C) and (D). OE, overexpression. Luc, luciferase; M, mutation.
Figure 5Direct binding of Dmrt1 to specific CRE within the Nile tilapia Sox30 promoter. (A) Chromatin immunoprecipitation (ChIP) assays of the binding of Dmrt1 to putative CRE in the Sox30 promoter in the testis of Nile tilapia at 90 dah. A primer pair covering the Sox30 promoter region containing putative CRE for Dmrt1 was used for PCR examination in the products precipitated from the Nile tilapia testes with an anti-Dmrt1 antibody. (B) Electrophoretic mobility shift assay (EMSA) analysis of the binding of Dmrt1 to specific CRE in the Nile tilapia Sox30 promoter. Specific probe against putative CRE for Dmrt1 was designed. The unlabeled intact probes could compete for the binding of Dmrt1 to the labeled intact probes in a dose-dependent manner. (C) The unlabeled probe with a mutation of putative CRE for Dmrt1 could not suppress the binding of Dmrt1 to the labeled intact probe.